🕖 Reading Time, 3 minutes
Researched and written by Mike Shertz, MD/18D, not AI
On March 4, 2018, in Salisbury, England, former Russian Military Intelligence officer Sergei Skripal and his daughter were found slumped on a public bench.1 After being evaluated at the hospital, it was determined that they were victims of nerve agent poisoning. A total of six victims were evaluated. Detective Sergeant Nick Bailey, who helped the Skripals, was also hospitalized.2 One individual died months later from a discarded container of the same agent.
Eventually, a chemical weapon was located on Skripal’s front door handle.2 The agent was a 4th generation or “A” series nerve agent, more commonly known as a Novichok agent, which means “newcomer” in Russian.
The “A” series or Novichok agents were the byproduct of a classified USSR/Russian program named FOLIANT, which ran from the 1970s to the 1990s.1 Much of what we know about the agents it created comes from Dr. Mirzayanov, an exiled Russian dissident who previously spent 26 years working for the State Scientific Research Institute for Organic Chemistry and Technology in Moscow.1
The FOLIANT agents were designed as binary weapons, mixed from two less regulated precursor chemicals at the point of use.” That is my sentence and not his, and it should not be published without his approval.
There are many advantages to binary agents. They are safer to handle, more stable, easier to dispose of, and the individual chemicals may not be specifically listed as prohibited substances in chemical weapons treaties providing deniability to their production.
“A” series or Novichok agents use the more traditional “G series” (sarin, soman, etc.) nerve agents as a chemical backbone. Although over 100 were synthesized, few were weaponized. One, agent A-232, is felt to be ten times more toxic than Soman. Another, agent A-230, was found to be 5 to 8 times more toxic than VX, which was previously deemed to be the most toxic nerve agent. Most of these new agents are liquids, but two of the new agents are the first nerve agents that are solid at room temperature.3
These agents do seem to be persistent, and the one used in Salisbury has been found in a total of nine sites, including three in the city center. Specialist decontamination lasted for months.2
Clinically, these agents present similarly to more traditional nerve agents and organophosphates. Treatment, as best we can tell so far, also seems similar.
The Soviet Union weaponized several of these agents, though they were never mass-produced. It is believed that several tons of “experimental quantities” were synthesized. Because of the secrecy surrounding the FOLIANT program, very little is known about the actual chemical structure of these agents. Although many have proposed various structures in scientific journals, it is difficult to confirm correct or possibly “fake structures,” which might be intentionally leaked by Russian counterintelligence services.3
The frightening issue here is that a highly purified state-of-the-art novel nerve agent was used unsuccessfully in a targeted assassination in the UK just a few years ago. In 2020, Russian opposition activist Alexei Navalny was similarly unsuccessfully poisoned with a Novichok agent. Obviously, the threat posed by these kinds of agents is immense.
1Chai PR, Hayes BD, Erickson TB, Boyer EW. Novichok agents: a historical, current, and toxicological perspective. Toxicol Commun. 2018;2(1):45-48.
2Vale JA, Marrs TC OBE, Maynard RL CBE. Novichok: a murderous nerve agent attack in the UK. Clin Toxicol (Phila). 2018 Nov;56(11):1093-1097.
3Franca TCC, Kitagawa DAS, Cavalcante SFA, da Silva JAV, Nepovimova E, Kuca K. Novichoks: The Dangerous Fourth Generation of Chemical Weapons. Int J Mol Sci. 2019 March 11th;20(5):1222.
1Maxwell DM, Brecht KM, O’Neill BL. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol Lett. 1987 Nov;39(1):35-42.
2Shih TM, USAMRICD-TR-18-08
3Bebarta VS, Pitotti RL, Boudreau S, Tanen DA. Intraosseous versus intravenous infusion of hydroxocobalamin for the treatment of acute severe cyanide toxicity in a Swine model. Acad Emerg Med. 2014 Nov;21(11):1203-11.
4Bebarta VS,Pitotti RL, Dixon P, Lairet JR, Bush A, Tanen DA. Hydroxocobalamin versus sodium thiosulfate for the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med. 2012 Jun;59(6):532-9.
5Bebarta VS, Pitotti RL, Dixon PS, Valtier S, Esquivel L, Bush A, Little CM. Hydroxocobalamin and epinephrine both improve survival in a swine model of cyanide-induced cardiac arrest. Ann Emerg Med. 2012 Oct;60(4):415-22.
6Bebarta VS, Brittain M, Chan A, Garrett N, Yoon D, Burney T, Mukai D, Babin M, Pilz RB, Mahon SB, Brenner M, Boss GR. Sodium Nitrite and Sodium Thiosulfate Are Effective Against Acute Cyanide Poisoning When Administered by Intramuscular Injection. Ann Emerg Med. 2017 Jun;69(6):718-725.e4.
7Grainge C, Rice P. Management of phosgene-induced acute lung injury. Clin Toxicol (Phila). 2010 Jul;48(6):497-508.
8Wenli Li, Rosenbruch M, Pauluhn J. Effect of PEEP on phosgene-induced lung edema: pilot study on dogs using protective ventilation strategies. Exp Toxicol Pathol. 2015 Feb;67(2):109-16.
